Clinical trials
Active, not recruiting Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
551 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 4 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 9 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 8 |
| 2014 | 14 |
| 2015 | 13 |
| 2016 | 18 |
| 2017 | 27 |
| 2018 | 37 |
| 2019 | 43 |
| 2020 | 37 |
| 2021 | 62 |
| 2022 | 53 |
| 2023 | 83 |
| 2024 | 62 |
| 2025 | 48 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 551 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 27 |
| AbbVie | 26 |
| Memorial Sloan Kettering Cancer Center | 14 |
| St. Jude Children's Research Hospital | 14 |
| National Cancer Institute (NCI) | 12 |
| AstraZeneca | 11 |
| University Health Network, Toronto | 9 |
| Genmab | 7 |
| Amgen | 6 |
| UNC Lineberger Comprehensive Cancer Center | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 551 |
| Neoplasm Metastasis | 41 |
| Carcinoma, Non-Small-Cell Lung | 39 |
| Breast Neoplasms | 38 |
| Colorectal Neoplasms | 33 |
| Lung Neoplasms | 31 |
| Melanoma | 23 |
| Prostatic Neoplasms | 23 |
| Recurrence | 21 |
| Lymphoma | 20 |
Trials
Showing 26 to 50 of 551. Each trial links to its page on Pharma Observatory.
451 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.